Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Transcode Therapeutics (RNAZ)
Squarespace, Inc. (SQSP)
Procore Technologies, Inc. (PCOR)
Oatly Group Ab (OTLY)
Ziprecruiter, Inc. (ZIP)
Priced IPO
Save Foods (SVFD)
Vera Therapeutics, Inc. (VERA)
Digital Brands Group, Inc. (DBGI)
Ipower Inc. (IPW)
Global-e Online Ltd. (GLBE)
Similarweb Ltd. (SMWB)
Flora Growth (FLGC)
Anebulo Pharmaceuticals (ANEB)
Bowman Consulting Group Ltd. (BWMN)
Onion Global Limited (OG)
Waterdrop Inc. (WDH)
Talaris Therapeutics, Inc. (TALS)
Valneva Se (VALN)
Five Star Bancorp (FSBC)
The Honest Company Inc. (HNST)
Alfi, Inc. (ALF)
Red Cat Holdings (RCAT)
Werewolf Therapeutics Inc. (HOWL)
Vaccitech Plc. (VACC)
Endeavor Group Holdings (EDR)
More companies

Akoya Biosciences, Inc. (AKYA)

Sector - Healthcare

Price chart

+1.58%
Return from IPO

Company News

IPO Profile

About company

Company Logo
They are an innovative life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. Their mission is to deliver a revolutionary new class of spatially derived biomarkers that empower life sciences researchers to better understand disease and clinicians to improve patient outcomes. Spatial biology refers to a rapidly evolving technology that enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through their CODEX and Phenoptics platforms, reagents, software and services, they offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum, from discovery through translational and clinical research.
Industry
Laboratory Analytical Instruments
CEO CFO
Brian McKelligon Joseph Driscoll
Employees Founded
169 2015

Contacts

Address: 100 Campus Drive, 6th Floor Marlborough, Ma 01752

Telephone: (855) 896-8401

Web page: http://www.akoyabio.com

IPO information

First Trade Date 4/16/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 6.6
Shares Revised (MM) 6.6
Expected offer amount (MM) $125.4
Realized offer amount(MM) $132

Financial Data (last reporting year)

Market Cap (MM) $678.11
Revenues (MM) $42.44
Net Income (Loss) (MM) $-16.71

Voting

What do you think will happen with the AKYA share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: JP Morgan

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
JP Morgan/ Morgan Stanley/ Piper Sandler/ Canaccord Genuity
CO-Managers
-

Sector: Healthcare

Tweets about $AKYA

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats